col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

ST Bio-life: Melatonin Research
  original article Date Title Authors   All Authors
1 [GO] 2021―Apr―30 Does the melatonin supplementation decrease the severity of the outcomes in COVID-19 patients? A mini review of observational data in the in vivo and in vitro studies Mohammad Gholizadeh, Faezeh Abaj, Hossein Hasani, Atieh Mirzababaei, Khadijeh Mirzaei
2 [GO] 2021―Jan―04 Melatonin: A potential therapeutic agent against COVID-19 Sangiliyandi Gurunathan, Min-Hee Kang, Youngsok Choi, Russel J Reiter, Jin-Hoi Kim
3 [GO] 2021―Jan―04 Efficacy of melatonin in non-intensive care unit patients with COVID-19 pneumonia and sleep dysregulation Luis I. Brusco, Pablo Cruz, Alicia V Cangas, Carmen González Rojas, Daniel E Vigo, Daniel Pedro Cardinali
4 [GO] 2021―Jan―04 Melatonin-Index as a biomarker for predicting the distribution of presymptomatic and asymptomatic SARS-CoV-2 carriers Pedro A Fernandes, Gabriela S Kinker, Bruno V Navarro, Vinicius C Jardim, Edson D Ribeiro-Paz, Marlina O Córdoba-Moreno, et al. (+7)
5 [GO] 2021―Jan―04 An urgent proposal for the immediate use of melatonin as an adjuvant to anti- SARS-CoV-2 vaccination Daniel P Cardinali, Gregory M Brown, Seithikurippu R Pandi-Perumal
6 [GO] 2020―Oct―09 Avoiding room light during night may stimulate immunity in COVID-19 patients by promoting melatonin production Murtada Ahmed Ahmed
7 [GO] 2020―Oct―09 Low melatonin as a contributor to SARS-CoV-2 disease Seithikurippu R Pandi-Perumal, Daniel P Cardinali, Russel J Reiter, Gregory M Brown
8 [GO] 2020―Oct―09 Melatonin attenuates growth factor receptor signaling required for SARS-CoV-2 replication Jan Tesarik
9 [GO] 2020―Jun―15 Estimated doses of melatonin for treating deadly virus infections: focus on COVID-19 Dun-Xian Tan, Rüdiger Hardeland
10 [GO] 2020―Jun―15 Protection by melatonin in respiratory diseases: valuable information for the treatment of COVID-19 Ruediger Hardeland, Dun-Xian Tan
11 [GO] 2020―Jun―15 Melatonin as a potential therapeutic molecule against COVID-19 associated gastrointestinal complications: An unrevealed link Palash Kumar Pal, Aindrila Chattopadhyay, Debasish Bandyopadhyay
12 [GO] 2020―Jun―15 Plasticity of glucose metabolism in activated immune cells: advantages for melatonin inhibition of COVID-19 disease Russel J Reiter, Ramaswamy Sharma, Qiang Ma, Changwei Liu, Walter Manucha, Pedro Abreu-Gonzalez, Alberto Dominguez-Rodriguez
13 [GO] 2020―Jun―15 High doses of melatonin as a potential therapeutic tool for the neurologic sequels of covid-19 infection Daniel Pedro Cardinali
14 [GO] 2020―Jun―15 COVID-19 pathophysiology: interactions of gut microbiome, melatonin, vitamin D, stress, kynurenine and the alpha 7 nicotinic receptor: Treatment implications George Anderson, Russel J Reiter
15 [GO] 2020―Jun―15 Melatonin, cardiovascular disease and COVID-19: A potential therapeutic strategy? Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez, Paul E Marik, Russel J Reiter
16 [GO] 2020―Jun―15 Melatonin as adjuvant treatment for coronavirus disease 2019 pneumonia patients requiring hospitalization (MAC-19 PRO): a case series Rafael Ricafranca Castillo, Gino Rei A. Quizon, Mario Joselito M. Juco, Arthur Dessi E. Roman, Donnah G De Leon, Felix Eduardo R. Punzalan, et al. (+4)
17 [GO] 2020―Jun―15 The potential of melatonin in the prevention and attenuation of oxidative hemolysis and myocardial injury from cd147 SARS-CoV-2 spike protein receptor binding Doris Loh
18 [GO] 2020―Jun―15 ER stress and autophagy induced by SARS-CoV-2: The targets for melatonin treatment Jose Antonio Boga, Ana Coto-Montes
19 [GO] 2020―Mar―23 Potential utility of melatonin in deadly infectious diseases related to the overreaction of innate immune response and destructive inflammation: focus on COVID-19 Dunxian X Tan, Ruegiger Hardeland


Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.005 sec